Showing results (251-260 of 270) with videos related to
Sort By:
Pageof 27
Journal of Gastroenterology and Hepatology|May 1, 2014
Issues associated with the emergence of coeliac disease in the Asia–Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of GastroenterologyGovind K Makharia, Chris J J Mulder, Khean Lee Goh, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In UteroRalley Prentice, Emma Flanagan, Emily K Wright, et al.Journal of Crohn'S & Colitis|July 2, 2022
Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 ChildrenZheng Liu, Mette Julsgaard, Xiao Zhu, et al.Journal of Crohn'S & Colitis|December 19, 2013
Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational studyPeter R Gibson, Carolynne Vaizey, Christopher M Black, et al.Journal of Gastroenterology and Hepatology|April 8, 2010
The Asia-Pacific consensus on ulcerative colitisChoon Jin Ooi, Kwong Ming Fock, Govind K Makharia, et al.Gut|August 15, 2019
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?Mayur Garg, Simon G Royce, Chris Tikellis, et al.Neurogastroenterology and Motility|February 11, 2026
Accelerometric Assessment of Gastric Contractility Using the Atmo Wireless Motility CapsuleWilliam L Hasler, Thomas Abell, Ashok Attaluri, et al.Alimentary Pharmacology & Therapeutics|September 27, 2020
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposureEmma Flanagan, Peter R Gibson, Emily K Wright, et al.The American Journal of Gastroenterology|September 29, 2025
Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel DiseaseRobert D Little, Thisun C Jayawardana, Fan Zhang, et al.Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.Pageof 27